1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Post-kala-azar Dermal Leishmaniasis: new trials by email Literature Review of Post-kala-azar Dermal Leishmaniasis trials Research Report on Post-kala-azar Dermal Leishmaniasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL) Vaccine, Placebo - Post-kala-azar Dermal Leishmaniasis | Phase 2 | Withdrawn | University of York | 2023-10-01 | 2022-09-30 |
Vaccines (1)
Paul M Kaye, PhD (1)